Japan eyes mixed use of COVID-19 shots to speed vaccine rollout

0
28
imageCoronavirus News4 hours ago (Aug 29, 2021 09:20)

© Reuters. FILE PHOTO: A medical worker picks a syringe as she gives an injection of COVID-19 vaccination at the Tokyo Metropolitan Government office in Tokyo as Tokyo Metropolitan Government started vaccination for the persons involved in the Tokyo 2020 Olympic Gam

TOKYO (Reuters) – Japan is looking into the possibility of mixing shots of AstraZeneca (NASDAQ:AZN) Plc’s COVID-19 vaccine with those developed by other drug makers in a bid to speed up its vaccine rollout, the minister in charge of vaccinations said on Sunday.

Japan, which has previously relied on the Pfizer (NYSE:PFE) Inc/BioNTech SE and Moderna (NASDAQ:MRNA) Inc vaccines, approved AstraZeneca’s vaccine in July and has secured two million doses.

“I have asked the health ministry to come up with an opinion about the use of AstraZeneca vaccines for the first dose and Pfizer’s with the second, or the AstraZeneca’s as the first shot and Moderna as second,” vaccine programme chief Taro Kono said on the Fuji Television network.

This could speed up the vaccination rollout by shortening the intervals between the first and second shots when using the AstraZeneca vaccine, he said.

AstraZeneca’s two shots are administered with an interval of eight weeks, longer than for the other vaccines.

Japan is battling its worst wave of infections, driven by the Delta variant, with new daily infections exceeding 25,000 this month for the first time.

The country’s vaccination ratio has lagged other developed nations. Japan has inoculated 54% of its population with at least one dose and fully vaccinated 43%, according to a Reuters vaccine tracker.

Japan eyes mixed use of COVID-19 shots to speed vaccine rollout

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

LEAVE A REPLY

Please enter your comment!
Please enter your name here